Results 241 to 250 of about 62,107 (256)

Human medicines European public assessment report (EPAR): Kromeya, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Osteoporosis in Early Ankylosing Spondylitis: A Primary Pathological Event?

Lancet, The, 1989
Andrei Calin, A K Bhalla, Andrei Calin
exaly  

Human medicines European public assessment report (EPAR): Halimatoz, adalimumab, Hidradenitis Suppurativa,Psoriasis,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 26/07/2018, Revision: 3, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Hulio, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 16/09/2018, Revision: 1, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Pathogenesis of Ankylosing Spondylitis

Nature Reviews Rheumatology, 2010
Lai-Shan Tam, Jieruo Gu, David Yu
exaly  

Human medicines European public assessment report (EPAR): Hulio, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 16/09/2018, Revision: 2, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Cyltezo, adalimumab, Hidradenitis Suppurativa,Arthritis, Psoriatic,Psoriasis,Crohn Disease,Arthritis, Juvenile Rheumatoid,Uveitis,Arthritis, Rheumatoid,Colitis, Ulcerative,Spondylitis, Ankylosing, Date of authorisation: 10/11/2017, Revision: 2, Status: Withdrawn

Case Medical Research, 2019
openaire   +2 more sources

Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Arthritis,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 24/08/2017, Revision: 10, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Hidradenitis Suppurativa,Psoriasis,Crohn Disease,Uveitis,Arthritis, Rheumatoid,Arthritis,Colitis, Ulcerative,Spondylitis, Ankylosing,Arthritis, Psoriatic, Date of authorisation: 24/08/2017, Revision: 8, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source

Human medicines European public assessment report (EPAR): Kromeya, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Revision: 2, Status: Authorised

Case Medical Research, 2019
openaire   +1 more source